Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · April 28, 2015

Comparison of Neoadjuvant Therapies for Muscle-Invasive Bladder Cancer

Cancer

 

Additional Info

Cancer
Comparative Effectiveness of Gemcitabine Plus Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
Cancer 2015 Apr 14;[EPub Ahead of Print], MD Galsky, SK Pal, S Chowdhury, LC Harshman, SJ Crabb, YN Wong, EY Yu, T Powles, EL Moshier, S Ladoire, SA Hussain, N Agarwal, UN Vaishampayan, F Recine, D Berthold, A Necchi, C Theodore, MI Milowsky, J Bellmunt, JE Rosenberg

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading